ClinVar Miner

Submissions for variant NM_206933.3(USH2A):c.8320G>A (p.Ala2774Thr) (rs111033533)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Hearing Loss Variant Curation Expert Panel RCV000787983 SCV000927006 likely benign Usher syndrome 2019-03-25 reviewed by expert panel curation The filtering allele frequency of the p.Ala2774Thr variant in the USH2A gene is 0.13% for European Finnish chromosome by gnomAD (35/25118), and one homozygous European (Finnish) individual and one homozygous European (non-Finnish) individual (BS1_Supporting). The REVEL computational prediction analysis tool predicted a score of 0.052, which meets the threshold to apply BP4. In summary, the HL EP classified this variant as likely benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1_Supporting, BP4.
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000041923 SCV000065619 likely benign not specified 2010-02-17 criteria provided, single submitter clinical testing
Counsyl RCV000664992 SCV000789042 uncertain significance Usher syndrome, type 2A; Retinitis pigmentosa 39 2016-12-27 criteria provided, single submitter clinical testing
Invitae RCV000910955 SCV001056008 likely benign not provided 2019-12-31 criteria provided, single submitter clinical testing
NIHR Bioresource Rare Diseases, University of Cambridge RCV000504908 SCV000598833 uncertain significance Retinal dystrophy 2015-01-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.